- Home
- SRE vs ALC Comparison
SRE vs ALC Comparison
Compare SRE & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRE
- ALC
- Stock Information
- Founded
- SRE 1998
- ALC 1945
- Country
- SRE United States
- ALC Switzerland
- Employees
- SRE N/A
- ALC N/A
- Industry
- SRE Oil/Gas Transmission
- ALC Ophthalmic Goods
- Sector
- SRE Utilities
- ALC Health Care
- Exchange
- SRE Nasdaq
- ALC Nasdaq
- Market Cap
- SRE 58.4B
- ALC 47.7B
- IPO Year
- SRE N/A
- ALC N/A
- Fundamental
- Price
- SRE $93.11
- ALC $85.51
- Analyst Decision
- SRE Strong Buy
- ALC Strong Buy
- Analyst Count
- SRE 11
- ALC 14
- Target Price
- SRE $89.00
- ALC $102.12
- AVG Volume (30 Days)
- SRE 3.1M
- ALC 1.1M
- Earning Date
- SRE 11-06-2024
- ALC 11-12-2024
- Dividend Yield
- SRE 2.67%
- ALC 0.31%
- EPS Growth
- SRE 5.10
- ALC 156.61
- EPS
- SRE 4.54
- ALC 2.34
- Revenue
- SRE $12,918,000,000.00
- ALC $9,761,000,000.00
- Revenue This Year
- SRE N/A
- ALC $6.14
- Revenue Next Year
- SRE $7.34
- ALC $6.55
- P/E Ratio
- SRE $20.51
- ALC $36.49
- Revenue Growth
- SRE N/A
- ALC 5.25
- 52 Week Low
- SRE $66.40
- ALC $71.46
- 52 Week High
- SRE $93.90
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- SRE 69.32
- ALC 25.71
- Support Level
- SRE $90.25
- ALC $83.92
- Resistance Level
- SRE $93.12
- ALC $86.86
- Average True Range (ATR)
- SRE 2.27
- ALC 1.77
- MACD
- SRE 0.52
- ALC -0.54
- Stochastic Oscillator
- SRE 94.27
- ALC 16.31
About SRE DBA Sempra
Sempra Energy serves one of the largest utility customer bases in the United States. It distributes natural gas and electricity in Southern California and owns 80% of Oncor, a transmission and distribution business in Texas. SoCalGas and San Diego Gas & Electric distribute gas to more than 20 million customers, while Oncor serves more than 10 million Texas customers. Sempra Infrastructure partners, of which Sempra holds a controlling ownership, owns and operates liquefied natural gas facilities in North America and infrastructure in Mexico.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.